Concepedia

Edward J. Gonzalez

EJ

10

Publications

910

Citations

10

H-Index

2004

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Sheba Medical Center

Tel Aviv Sourasky Medical Center

University of Chicago

Moffitt Cancer Center

Edward J. Gonzalez is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, radiation oncology, and oncology.

Top concepts

Publications per year

2004–2015

10

Publications

10

Safety and efficacy of sitagliptin in patients with type 2 diabetes and chronic renal insufficiency

Juliana C.N. Chan, Russell Scott, Juan Camilo Arjona Ferreira et al. · Diabetes Obesity and Metabolism · 2008 · 238 citations

Efficacy and Safety of Sitagliptin in Patients With Type 2 Diabetes and ESRD Receiving Dialysis: A 54-Week Randomized Trial

Juan Camilo Arjona Ferreira, Dalila B. Corry, Carl Erik Mogensen et al. · American Journal of Kidney Diseases · 2013 · 128 citations

, , +11

Relationship between PD-L1 expression and clinical outcomes in patients (Pts) with advanced gastric cancer treated with the anti-PD-1 monoclonal antibody pembrolizumab (Pembro; MK-3475) in KEYNOTE-012.

Kei Muro, Yung‐Jue Bang, Veena Shankaran et al. · Journal of Clinical Oncology · 2015 · 118 citations

, , +15

Abstract S1-09: A phase Ib study of pembrolizumab (MK-3475) in patients with advanced triple-negative breast cancer

Rita Nanda, Laura Q.M. Chow, E. Claire Dees et al. · Cancer Research · 2015 · 114 citations

, , +17

Discovery of potent and selective β-homophenylalanine based dipeptidyl peptidase IV inhibitors

Jinyou Xu, Hyun Ok, Edward J. Gonzalez et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 76 citations · Full text

, , +7

Rows per page

1–5 of 10